Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
2(20%)
Results Posted
83%(5 trials)
Terminated
2(20%)

Phase Distribution

Ph phase_2
3
30%
Ph phase_3
1
10%
Ph phase_1
3
30%

Phase Distribution

3

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
3(42.9%)
Phase 2Efficacy & side effects
3(42.9%)
Phase 3Large-scale testing
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(6)
Terminated(2)

Detailed Status

Completed6
Terminated2
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (42.9%)
Phase 23 (42.9%)
Phase 31 (14.3%)

Trials by Status

terminated220%
active_not_recruiting110%
completed660%
recruiting110%

Recent Activity

2 active trials
Showing 5 of 10
active_not_recruiting

Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis

NCT04217356
completedphase_1

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

NCT02356159
recruiting

Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis

NCT02934477
completedphase_2

Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701)

NCT00912223
completedphase_2

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

NCT01998633
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT04217356

Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis

Active Not Recruiting
NCT02356159Phase 1

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

Completed
NCT02934477

Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis

Recruiting
NCT00912223Phase 2

Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701)

Completed
NCT01998633Phase 2

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

Completed
NCT02678143Phase 1

Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease

Terminated
NCT03482154

Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population

Completed
NCT00167206Phase 1

Stem Cell Transplantation for Fanconi Anemia

Terminated
NCT00186875Phase 2

Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia

Completed
NCT00186966Phase 3

Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia

Completed

All 10 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
10